@FlemmingBruce This reporter [email protected]">@industrydive.com">[email protected] clearly hasn't heard about the groundbreaking $NWBO #DCVax-L phase 3 results ALREADY PEER-REVIEWED & PUBLISHED IN JAMA. Or maybe he has. Statistically significant OS extension in BOTH new & re
@01Core_Ben @venuv62 @Noahpinion Huang says that because he wants to sustain an unsustainable share price. To my knowledge $NWBO didn't use a single $NVDA GPU for their revolutionary cancer vaccine, DCVax. AI will never replace the wet lab. https://t.c
RT @flaskworks: @dollarsanddata Time to look into $NWBO? https://t.co/UbQi4GbIF9
@dollarsanddata Time to look into $NWBO? https://t.co/UbQi4GbIF9
RT @flaskworks: @SnackBioTech @bohsie If you don't know the $NWBO trial data then maybe you shouldn't keep trolling the future SOC for brai…
https://t.co/bhUDKROm2Z… https://t.co/AqCgR5j5dY… https://t.co/v7s3GQwO01 $nwbo @alphavestcap
@SnackBioTech @bohsie If you don't know the $NWBO trial data then maybe you shouldn't keep trolling the future SOC for brain cancer patients. https://t.co/UbQi4GbIF9 https://t.co/NDF2KDCG6C https://t.co/T1G8rSgaQy
https://t.co/2rkIgxH1Uq In the P3 trail, documented by the JAMA scientific publication (11/17/22), what % of the dosed patients( c. 300 ?) lived longer ? $nwbo @alphavestcap https://t.co/bhUDKROm2Z
RT @GoneGoodguy: You've been saying that for decades. #NWBO will not go bankrupt. SHFs couldn't stop NWBO when they had the stock on the ro…
@tradrjoze He has a right to his opinions, but the JAMA article, along with the plethora of doctors who support this, outweighs his statement: https://t.co/kMftDjsZ31
RT @GoneGoodguy: You've been saying that for decades. #NWBO will not go bankrupt. SHFs couldn't stop NWBO when they had the stock on the ro…
You've been saying that for decades. #NWBO will not go bankrupt. SHFs couldn't stop NWBO when they had the stock on the ropes at 14 cents. Surely, they can't stop it now! Here's a few reasons why: 1.https://t.co/kLHpSzE65Z 2. https://t.co/wTpMKKf44S 3.
@davidasinclair Well worth looking into IMO. Three places to start: The P3 trial: https://t.co/CyiZz8aWF2 Proteomics analysis presentation: https://t.co/rLzNWzc6gz Upcoming combo trial results in Nature (preprint atm): https://t.co/bdlxG2N5QS Future
@Pharmdca Then check out some recent research out of UCLA using $NWBO's DCVax. https://t.co/UbQi4GbIF9 https://t.co/NDF2KDCG6C
@jarlebreivik fokuserer på Glioblastoma multiforme, fase 3 studiet er nå er sendt inn til MHRA, for evaluering til en potensiell godkjenning. Resultatene er publisert i prestisjetunge JAMA oncologi https://t.co/ZXY9rbhsAx
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @miltommy56: Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/l4bp50sLaP
RT @miltommy56: Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/l4bp50sLaP
Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/l4bp50sLaP
@locuta Bij mijn weten is er geen Ned team betrokken bij deze klinische trial, maar ze zou het kunnen navragen bij het oncologische team van AvL. DCVax-L is een vaccin dat de prognose significant lijkt te verbeteren. Er zijn patienten gemeld met 8jr overl
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
RT @Dave46217976: $NWBO #DCVAX
RT @Dave46217976: $NWBO #DCVAX
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
$NWBO #DCVAX
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
RT @flaskworks: @Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, see…
$NWBO #DCVax
@Pharmdca Revenue potential for $NWBO, which has approved manufacturing for its personalized autologous cancer vaccine, seems astronomical. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/NDF2KDCG6C https://t.co/4wuqeo6jWO https://t.co/8
RT @rsloftx: @iluminatibot $nwbo #nwbo $dcvax #dcvax #murcidencel @GMA @LaraSpencer @RobinRoberts @cvpayne An example of corruption in th…
RT @rsloftx: @iluminatibot $nwbo #nwbo $dcvax #dcvax #murcidencel @GMA @LaraSpencer @RobinRoberts @cvpayne An example of corruption in th…
RT @rsloftx: @iluminatibot $nwbo #nwbo $dcvax #dcvax #murcidencel @GMA @LaraSpencer @RobinRoberts @cvpayne An example of corruption in th…
RT @rsloftx: @kasie @RobertKennedyJr @kasie $nwbo #nwbo $dcvax #dcvax #murcidencel @jeffstorobinsky Please read the JAMA abstract and t…
RT @rsloftx: @kasie @RobertKennedyJr @kasie $nwbo #nwbo $dcvax #dcvax #murcidencel @jeffstorobinsky Please read the JAMA abstract and t…
RT @rsloftx: @iluminatibot $nwbo #nwbo $dcvax #dcvax #murcidencel @GMA @LaraSpencer @RobinRoberts @cvpayne An example of corruption in th…
RT @rsloftx: @kasie @RobertKennedyJr @kasie $nwbo #nwbo $dcvax #dcvax #murcidencel @jeffstorobinsky Please read the JAMA abstract and t…
RT @rsloftx: @iluminatibot $nwbo #nwbo $dcvax #dcvax #murcidencel @GMA @LaraSpencer @RobinRoberts @cvpayne An example of corruption in th…
@kasie @RobertKennedyJr @kasie $nwbo #nwbo $dcvax #dcvax #murcidencel @jeffstorobinsky Please read the JAMA abstract and the 3 supplements for this ground breaking cancer treatment with no side effects and was found to be statistically significant. ht
RT @rsloftx: @iluminatibot $nwbo #nwbo $dcvax #dcvax #murcidencel @GMA @LaraSpencer @RobinRoberts @cvpayne An example of corruption in th…
@iluminatibot $nwbo #nwbo $dcvax #dcvax #murcidencel @GMA @LaraSpencer @RobinRoberts @cvpayne An example of corruption in the cancer field can be found in the lawsuit @NWBO is currently engaged in against 7 Market Makers - Ken Griffin @Citadel @citsecuri
RT @flaskworks: @DrVickersMSK @Citadel @MSKCancerCenter Why accept donation from Citadel which are being sued by @NorthwestBio for stock ma…
RT @flaskworks: @DrVickersMSK @Citadel @MSKCancerCenter Why accept donation from Citadel which are being sued by @NorthwestBio for stock ma…
RT @flaskworks: @DrVickersMSK @Citadel @MSKCancerCenter Why accept donation from Citadel which are being sued by @NorthwestBio for stock ma…
RT @flaskworks: @DrVickersMSK @Citadel @MSKCancerCenter Why accept donation from Citadel which are being sued by @NorthwestBio for stock ma…
RT @flaskworks: @DrVickersMSK @Citadel @MSKCancerCenter Why accept donation from Citadel which are being sued by @NorthwestBio for stock ma…
RT @flaskworks: @DrVickersMSK @Citadel @MSKCancerCenter Why accept donation from Citadel which are being sued by @NorthwestBio for stock ma…
$nwbo
RT @flaskworks: @DrVickersMSK @Citadel @MSKCancerCenter Why accept donation from Citadel which are being sued by @NorthwestBio for stock ma…
RT @flaskworks: @DrVickersMSK @Citadel @MSKCancerCenter Why accept donation from Citadel which are being sued by @NorthwestBio for stock ma…
@DrVickersMSK @Citadel @MSKCancerCenter Why accept donation from Citadel which are being sued by @NorthwestBio for stock manipulation? https://t.co/6cOnGpju64 $NWBO developed first personalized autologous vaccine for terminal Glioblastoma. Read more abo
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @albtur_mnymkrs: @TedTheBigRedDog Hello, what information were you looking for? Maybe I can direct you. I don’t have anything clickable…
@mabbpah @metacollectiveG @MDendream @dcvaxdaw @JackNdreu Nobody cares about your opinion on $NWBO https://t.co/Y7qysnUE1z
RT @Silver_Suntan: @InvestorTurf Citadel (and others) are also being sued for engaging in manipulative spoofing of a small biotech called $…
RT @DocOck222: Dr. Linda Liau is an American Hero !!!! 🦸🏻♀️🇺🇸 👩🏻⚕️
RT @Silver_Suntan: @InvestorTurf Citadel (and others) are also being sued for engaging in manipulative spoofing of a small biotech called $…
RT @Silver_Suntan: @InvestorTurf Citadel (and others) are also being sued for engaging in manipulative spoofing of a small biotech called $…
@InvestorTurf Citadel (and others) are also being sued for engaging in manipulative spoofing of a small biotech called $NWBO who has a promising and JAMA published immunotherapy for brain cancer called DC-VAX. https://t.co/K6WF6e9J1o https://t.co/BtKx3B0
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @apwriter: $nwbo
RT @johnlane45: $NWBO #DCVax
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO
RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @rsloftx: $nwbo #nwbo $dcvax #dcvax #murcidencel
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @apwriter: $nwbo
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR
RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…
RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO
RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO
RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…